ECO Animal Health Group (LON:EAH) Receives “Buy” Rating from Shore Capital

ECO Animal Health Group (LON:EAH)‘s stock had its “buy” rating reaffirmed by research analysts at Shore Capital in a note issued to investors on Monday,Digital Look reports.

ECO Animal Health Group Price Performance

LON EAH remained flat at GBX 60 ($0.76) during trading on Monday. 100,236 shares of the company were exchanged, compared to its average volume of 61,427. The company has a market capitalization of £40.66 million, a price-to-earnings ratio of 38.79 and a beta of -0.05. The firm’s fifty day moving average is GBX 64.33 and its 200-day moving average is GBX 77.34. The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.81. ECO Animal Health Group has a 52-week low of GBX 56.60 ($0.72) and a 52-week high of GBX 135 ($1.72).

ECO Animal Health Group (LON:EAH) last announced its quarterly earnings results on Thursday, November 28th. The company reported GBX (2.50) (($0.03)) earnings per share for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.